Drugs & Targets Merck pays $35M to Kelun-Biotech for rights to investigational antibody drug conjugate July 29, 2022Vol.48 No.30
Drugs & Targets Mission Bio establishes early access program for single-cell measurable residual disease detection in blood cancers July 29, 2022Vol.48 No.30
In Brief $10M gift from Brock family to establish Brock Family Center for Applied Innovation at VUMC July 22, 2022Vol.48 No.29
In Brief Sarah Quinlan named chief program officer of Lymphoma Research Foundation July 22, 2022Vol.48 No.29
In Brief Researchers receive $9M NCI grant for imaging tech in clinical trials July 22, 2022Vol.48 No.29
In Brief University Hospitals Cleveland Medical Center named first SpaceOAR Hydrogel Center of Excellence in the world July 22, 2022Vol.48 No.29
